P1 Latency as a Biomarker for Central Auditory Development in Children with Hearing Impairment Journal Article uri icon



  • We used the latency of the P1 cortical auditory-evoked potential (CAEP) as a biomarker for the development of central auditory pathways in three children who received intervention through hearing aids and/or cochlear implants. Our goal was to examine the clinical feasibility of using the latency of the P1 CAEP as an objective tool to evaluate whether acoustic amplification for hearing-impaired children has provided sufficient stimulation for normal development of central auditory pathways. If clinicians have such a marker, then they can more confidently make a decision about whether to provide a child with a cochlear implant following an appropriate hearing-aid trial. Using the same marker, clinicians will also be able to monitor the maturation of central auditory pathways once electrical stimulation is initiated.

publication date

  • September 1, 2005

has restriction

  • closed

Date in CU Experts

  • November 2, 2014 9:44 AM

Full Author List

  • Sharma A; Martin K; Roland P; Bauer P; Sweeney MH; Gilley P; Dorman M

author count

  • 7

Other Profiles

International Standard Serial Number (ISSN)

  • 1050-0545

Electronic International Standard Serial Number (EISSN)

  • 2157-3107

Additional Document Info

start page

  • 564

end page

  • 573


  • 16


  • 08